Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295817432> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4295817432 endingPage "S768" @default.
- W4295817432 startingPage "S767" @default.
- W4295817432 abstract "An effective DNA damage response (DDR) is essential for cell survival. Elimusertib inhibits the ataxia-telangiectasia and RAD3-related (ATR) protein kinase, which is activated in response to DNA damage and mediates cell cycle arrest to maintain genomic integrity. Niraparib inhibits poly (ADP-ribose) polymerases 1/2 (PARP-1/2), which bind damaged regions of DNA and facilitate proper repair. Evidence suggests that combined inhibition of parallel DDR pathways act synergistically to improve anti-tumor responses, and the current study begins a clinical investigation of this hypothesis (NCT04267939)." @default.
- W4295817432 created "2022-09-15" @default.
- W4295817432 creator A5016318111 @default.
- W4295817432 creator A5021718862 @default.
- W4295817432 creator A5043098907 @default.
- W4295817432 creator A5062493010 @default.
- W4295817432 creator A5070567923 @default.
- W4295817432 creator A5074824233 @default.
- W4295817432 creator A5091608611 @default.
- W4295817432 creator A5072168296 @default.
- W4295817432 date "2022-09-01" @default.
- W4295817432 modified "2023-10-12" @default.
- W4295817432 title "494TiP Phase Ib study of elimusertib (ATRi; BAY 1895344) in combination with niraparib (PARPi) in patients with advanced solid tumors" @default.
- W4295817432 doi "https://doi.org/10.1016/j.annonc.2022.07.622" @default.
- W4295817432 hasPublicationYear "2022" @default.
- W4295817432 type Work @default.
- W4295817432 citedByCount "1" @default.
- W4295817432 crossrefType "journal-article" @default.
- W4295817432 hasAuthorship W4295817432A5016318111 @default.
- W4295817432 hasAuthorship W4295817432A5021718862 @default.
- W4295817432 hasAuthorship W4295817432A5043098907 @default.
- W4295817432 hasAuthorship W4295817432A5062493010 @default.
- W4295817432 hasAuthorship W4295817432A5070567923 @default.
- W4295817432 hasAuthorship W4295817432A5072168296 @default.
- W4295817432 hasAuthorship W4295817432A5074824233 @default.
- W4295817432 hasAuthorship W4295817432A5091608611 @default.
- W4295817432 hasBestOaLocation W42958174321 @default.
- W4295817432 hasConcept C111368507 @default.
- W4295817432 hasConcept C115880899 @default.
- W4295817432 hasConcept C121608353 @default.
- W4295817432 hasConcept C126322002 @default.
- W4295817432 hasConcept C127313418 @default.
- W4295817432 hasConcept C2993640289 @default.
- W4295817432 hasConcept C502942594 @default.
- W4295817432 hasConcept C71924100 @default.
- W4295817432 hasConceptScore W4295817432C111368507 @default.
- W4295817432 hasConceptScore W4295817432C115880899 @default.
- W4295817432 hasConceptScore W4295817432C121608353 @default.
- W4295817432 hasConceptScore W4295817432C126322002 @default.
- W4295817432 hasConceptScore W4295817432C127313418 @default.
- W4295817432 hasConceptScore W4295817432C2993640289 @default.
- W4295817432 hasConceptScore W4295817432C502942594 @default.
- W4295817432 hasConceptScore W4295817432C71924100 @default.
- W4295817432 hasLocation W42958174321 @default.
- W4295817432 hasOpenAccess W4295817432 @default.
- W4295817432 hasPrimaryLocation W42958174321 @default.
- W4295817432 hasRelatedWork W1506200166 @default.
- W4295817432 hasRelatedWork W1995515455 @default.
- W4295817432 hasRelatedWork W2048182022 @default.
- W4295817432 hasRelatedWork W2080531066 @default.
- W4295817432 hasRelatedWork W2604872355 @default.
- W4295817432 hasRelatedWork W2748952813 @default.
- W4295817432 hasRelatedWork W2899084033 @default.
- W4295817432 hasRelatedWork W3031052312 @default.
- W4295817432 hasRelatedWork W3032375762 @default.
- W4295817432 hasRelatedWork W3108674512 @default.
- W4295817432 hasVolume "33" @default.
- W4295817432 isParatext "false" @default.
- W4295817432 isRetracted "false" @default.
- W4295817432 workType "article" @default.